Kempharm Inc buy Quitte
Start price
15.06.16
/
50%
€4.26
Target price
15.12.16
€4.73
Performance (%)
-27.97%
End price
15.12.16
€3.07
Summary
This prediction ended on 15.12.16 with a price of €3.07. The price of Kempharm Inc has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -27.97%. Quitte has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Kempharm Inc | - | - | - | - |
| iShares Core DAX® | 0.060% | 1.215% | 18.128% | 70.406% |
| iShares Nasdaq 100 | -3.065% | -0.519% | 2.080% | 103.787% |
| iShares Nikkei 225® | -2.094% | -3.066% | 11.655% | 45.417% |
| iShares S&P 500 | -1.657% | -0.069% | 1.103% | 64.908% |
Comments by Quitte for this prediction
In the thread Kempharm Inc diskutieren
nach dem Absturz ist vor dem Anstieg
Shares of KemPharm Inc. (KMPH) were down over 26% in extended trading on Monday, following the receipt of FDA's complete response letter for the company's New drug Application for Apadaz.
(Laufzeit überschritten)